Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Larimar Therapeutics Inc. (LRMR)

11   -0.89 (-7.49%) 08-14 16:00
Open: 12.18 Pre. Close: 11.89
High: 12.18 Low: 11
Volume: 4,308 Market Cap: 169M
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases. The company's lead compound, CTI-1601, is being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich's ataxia, a rare and progressive genetic disease. It also focuses on using its proprietary protein replacement therapy platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. The company is based in Bala Cynwyd, Pennsylvania.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.198 - 12.259 12.259 - 12.31
Low: 10.869 - 10.929 10.929 - 10.978
Close: 10.913 - 11.006 11.006 - 11.083

Technical analysis

as of: 2020-08-14 4:32:01 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 14.61     One year: 17.07
Support: Support1: 10.35    Support2: 9.01
Resistance: Resistance1: 12.51    Resistance2: 14.61
Pivot: 11.18
Moving Average: MA(5): 11.22     MA(20): 11.29
MA(100): 61.00     MA(250): 103.37
MACD: MACD(12,26): -2.01     Signal(9): -2.88
Stochastic oscillator: %K(14,3): 67.24     %D(3): 61.73
RSI: RSI(14): 36.02
52-week: High: 243.36  Low: 9.01  Change(%): -91.0
Average Vol(K): 3-Month: 2515  10-Days: 1100

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
LRMR has closed above bottom band by 38.7%. Bollinger Bands are 96.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to LRMR's normal range. The bands have been in this narrow range for 40 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 11 Aug 2020
Stocks That Hit 52-Week Lows On Tuesday - Benzinga

Tue, 11 Aug 2020
Form 8-K Larimar Therapeutics, For: Aug 11 -

Tue, 11 Aug 2020
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results - GlobeNewswire

Tue, 04 Aug 2020
Larimar Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Conference - Yahoo Finance

Tue, 28 Jul 2020
Larimar Therapeutics Announces Positive Opinion on Orphan Drug Designation Received from the European Medicines Agency for CTI-1601 for the Treatment of Friedreich's Ataxia - GlobeNewswire

Wed, 22 Jul 2020
Biohaven's Phase 3 Trial, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 15
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K) 69
Shares Short P. Month (K) 116

Stock Financials

EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.633
Qtrly Earnings Growth
Operating Cash Flow (M) -26
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -6.55

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.